Sec Form 4 Filing - BIENAIME JEAN JACQUES @ BIOMARIN PHARMACEUTICAL INC - 2014-11-25

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person BIENAIME JEAN JACQUES 2. Issuer Name and Ticker or Trading Symbol BIOMARIN PHARMACEUTICAL INC [ BMRN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO ST. 3. Date of Earliest Transaction (MM/DD/YY) 11/25/2014 (Street) SAN RAFAEL, CA94901 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 11/25/2014( 1 ) 11/25/2014 M 2,000 A $ 12.99 45,195 I Shares held by Bienaime Family Trust ( 2 ) Common Stock 11/25/2014( 1 ) 11/25/2014 S 2,000 D $ 90 ( 3 ) 43,195 I Shares held by Bienaime Family Trust ( 2 ) Common Stock 229,157 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy Common Stock) $ 12.99 11/25/2014( 1 ) 11/25/2014 M 2,000 11/11/2006( 4 ) 05/10/2016 Common Stock 2,000 $ 0 69,500 ( 5 ) I Shares Held by Bienaime Family Trust ( 2 ) Stock Option (right to buy Common Stock) $ 12.99 11/11/2006( 4 ) 05/10/2016 Common Stock 10,000 10,000 I Held in irrevocable trust for Guillaume Bienaime ( 6 ) Stock Option (right to buy Common Stock) $ 12.99 11/11/2006( 4 ) 05/10/2016 Common Stock 10,000 10,000 I Held in irrevocable trust for Pierre Bienaime ( 6 ) Stock Option (right to buy Common Stock) $ 12.99 11/11/2006( 4 ) 05/10/2016 Common Stock 10,000 10,000 I Held in irrevocable trust for Paul Bienaime ( 6 ) Stock Option (right to buy Common Stock) $ 12.99 11/11/2006( 4 ) 05/10/2016 Common Stock 10,000 10,000 I Held in irrevocable trust for Marc Bienaime ( 6 ) Stock Option (right to buy Common Stock) $ 12.99 11/11/2006( 4 ) 05/10/2016 Common Stock 20,000 20,000 I Held in irrevocable trust for Aurelie Mitsuki Bienaime & Anais Kimiko Bienaime ( 6 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL, CA94901 X Chief Executive Officer Signatures /s/ Laura Randall Woodhead, Attorney-in-Fact 11/28/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Trade made pursuant to a 10b5-1 plan executed August 20, 2014 ( 2 )The reporting person an his spouse act as trustees for the Bienaime Family Trust ( 3 )All shares sold at same price ( 4 )Original option grant vests 6/48ths on November 11, 2006, and 1/48th on the 11th of every month thereafter. ( 5 )Reflects the number of stock options outstanding after the transaction from this specific stock option grant. ( 6 )The reporting person's spouse is the trustee of each child's trust.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.